This work has been developed in the context of AdvanceCat with the support of ACCIÓ (Catalonia Trade & Investment; Generalitat de Catalunya) under the Catalonian ERDF operational program (European Regional Development Fund) 2014-2020.

ADVANCE(CAT) general assembly to discuss the future of ATMPs

July 24, 2018

 

ADVANCE(CAT) general assembly organizes a seminar/debate about the future of ATMPs and the potential of Catalonia to be a key player in this promising field. A mix of political authorities, researchers, pharma executives and captial risk investors will stir the debate. Confirmed speakers are: 

Albert Barberà, Director General de Recerca e Innovació en Salut, Departament de Salut, Generalitat de Catalunya

Lluís Juncà, Director General de Promoció Econòmica, Competència i Regulació, Departament de la Vicepresidència i d'Economia i Hisenda, Generalitat de Catalunya

Francesc Cardellach, dean of Faculty of Medicine and Health Sciences, Universitat de Barcelona

Jordi Naval, Strategy Director, Biocat

Manel Juan, Head of Clinical Immunology, Hospital Clínic
Andrés Fernández, Director, Ferrer Advanced Biotherapeutics
Clara Campas, Co-founder, Asabys Partners

Antoni Bayes-Genis, Head of Cardiology Unit, Hospital Universitari Germans Trias i Pujol

 

The event is held at the Faculty of Medicine and Health Sciences of the University of Bareclona and is open to everybody, registration here: https://es.xing-events.com/assemblea_general_advancecat

Share on Facebook
Share on Twitter
Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Social Icon